Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Bausch Christoph Lawrence Create: Alert

All | News | Filings
Date FiledTypeDescription
11/24/2021 4/A Bausch Christoph Lawrence (Chief Science Officer) has filed a Form 4 on SAB Biotherapeutics, Inc.
Txns: Granted 104,689 options to buy @ $0.5, valued at $52.3k
Granted 81,425 options to buy @ $0.5, valued at $40.7k
Granted 108,086 options to buy @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy